Laboratory tests in primary care · by Dr Solange Déplanque and Dr Michaël Rochoy

Nocturia in adults

Urology and andrology · Symptom or situation · updated 2026-10-31

BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.

Frequency: In the Netherlands, 13% of adults have nocturia (at least two voids per night on average; age- and sex-standardised figure), i.e. 16% of women and 9% of men, with frequency rising with age (2001 telephone survey; non-French data) [1].

Initial tests

Fasting sample.

In the practice

Laboratory tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Do not order

Desmopressin: serum sodium before and after

Before treatment

Between D3 and D7

At 1 month

Detailed explanation and international comparison (in French): read it in English (machine translation)

Sources (13)
  1. van Dijk L, Kooij DG, Schellevis FG. Nocturia in the Dutch adult population. BJU Int. 2002;90(7):644-8.
  2. Haute Autorité de santé, Association française d'urologie. Bilans pré-thérapeutiques des troubles mictionnels de l'homme adulte : modalités et acteurs. Recommandation de bonne pratique, validée le 9 novembre 2023, mise à jour en avril 2024.
  3. Dawson S, Duncan L, Ahmed A, et al. Assessment and treatment of nocturia in endocrine disease in a primary care setting: systematic review and nominal group technique consensus. Eur Urol Focus. 2022;8(1):52-59.
  4. Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : acte 1577 (HbA1c) ; sous-chapitre 13-03 (urines).
  5. Everaert K, Hervé F, Bosch R, et al. International Continence Society consensus on the diagnosis and treatment of nocturia. Neurourol Urodyn. 2019;38(2):478-498.
  6. van Merode NAM, Dawson S, Coulthard EJ, et al. Assessment and treatment of nocturia in neurological disease in a primary care setting: systematic review and nominal group technique consensus. Eur Urol Focus. 2022;8(1):33-41.
  7. Papworth E, Dawson S, Henderson EJ, et al. Association of sleep disorders with nocturia: a systematic review and nominal group technique consensus on primary care assessment and treatment. Eur Urol Focus. 2022;8(1):42-51.
  8. Garcia Reyes PB, Butcher K, Cotterill N, et al. Implications of cardiovascular disease for assessment and treatment of nocturia in primary care: systematic review and nominal group technique consensus. Eur Urol Focus. 2022;8(1):26-32.
  9. Hashim H, Blanker MH, Drake MJ, et al. International Continence Society (ICS) report on the terminology for nocturia and nocturnal lower urinary tract function. Neurourol Urodyn. 2019;38(2):499-508.
  10. Ridgway A, Cotterill N, Dawson S, et al. Nocturia and chronic kidney disease: systematic review and nominal group technique consensus on primary care assessment and treatment. Eur Urol Focus. 2022;8(1):18-25.
  11. National Institute for Health and Care Excellence (NICE). Lower urinary tract symptoms in men: management. Clinical guideline CG97, mai 2010, dernière mise à jour juin 2015 (recommandations 1.1.3 à 1.1.7 et 1.4.10).
  12. Getaneh FW, Sussman RD, Iglesia CB. Nocturia: Evaluation and Management. Am Fam Physician. 2025;111(6):515-523B.
  13. ANSM. Résumé des caractéristiques du produit MINIRIN 0,1 mg, comprimé, et MINIRINMELT 60, 120 et 240 microgrammes, lyophilisat oral (desmopressine), rubriques 4.1 à 4.5. Base de données publique des médicaments (CIS 62822682 et 67275313), consultée le 12/10/2026 ; RCP mis à jour le 07/08/2026.